Análise angiográfica e ultra-sonográfica do stent liberador de novolimus para o tratamento de lesões coronárias de novo: resultados do estudo EXCELLA I

Maia, Felipe; Abizaid, Alexandre; Costa JUnior, José Ribamar; Feres, Fausto; Seixas, Ana Cristina; Staico, Rodolfo; Mattos, Luiz Alberto; Abizaid, Andréa; Costa, Ricardo A; Sousa, Amanda G. M. R; Sousa, J. Eduardo.
Rev. bras. cardiol. invasiva ; 16(2): 139-143, abr.-jun. 2008. tab, graf, ilus
Artículo en Portugués | LILACS, SES-SP | ID: lil-498766

Documentos relacionados

  1. A Novel Sirolimus-eluting Biodegradable Magnesium-based Alloy Scaffold: Six-month Results In Porcine Peripheral Arteries.
  2. Nanospheres encapsulated everolimus delivery into arterial wall-the tissue pharmacokinetics and vascular response experimental study.
  3. Comparison of Drug-Eluting Balloon Followed by Bare Metal Stent with Drug-Eluting Stent for Treatment of de Novo Lesions: Randomized, Controlled, Single-Center Clinical Trial.
  4. Sustained safety and performance of the second-generation drug-eluting absorbable metal scaffold in patients with de novo coronary lesions: 12-month clinical results and angiographic findings of the BIOSOLVE-II first-in-man trial.
  5. [Comparative results of using coronary drug-eluting stents 'NanoMed' and Orsiro].
  6. The Effects of Sirolimus and Magnesium on Primary Human Coronary Endothelial Cells: An In Vitro Study.
  7. [Inflammatory Markers and Their RoIe in Assessing Prognosis of patients With Stable Coronary Artery Disease After Coronary Stenting].
  8. Randomized Comparison of Ridaforolimus- and Zotarolimus-Eluting Coronary Stents in Patients With Coronary Artery Disease: Primary Results From the BIONICS Trial (BioNIR Ridaforolimus-Eluting Coronary Stent System in Coronary Stenosis).
  9. Long-Term Comparison of Platinum Chromium Everolimus-Eluting Stent vs. Cobalt Chromium Zotarolimus-Eluting Stent　- 3-Year Outcomes From the HOST-ASSURE Randomized Clinical Trial.
  10. Pharmacokinetic principles of dose adjustment of mTOR inhibitors in solid organ transplanted patients.